The Emerging Role of Nanotechnology in Cell and Organ Transplantation.
暂无分享,去创建一个
Mauro Ferrari | Ennio Tasciotti | Malgorzata Kloc | Alessandro Grattoni | Michael Evangelopoulos | M. Ferrari | M. Kloc | E. Tasciotti | X. Li | A. Grattoni | Jonathan O. Martinez | F. Cabrera | M. Evangelopoulos | U. Thekkedath | R. Ghobrial | Rafik M Ghobrial | Jonathan O Martinez | Usha R Thekkedath | Fernando J Cabrera | Xian C Li
[1] C. Vogel,et al. Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience , 2002, Cancer investigation.
[2] I. Ko,et al. In vivo MR Imaging of Tissue-engineered Human Mesenchymal Stem Cells Transplanted to Mouse: a Preliminary Study , 2006, Annals of Biomedical Engineering.
[3] M. Dana,et al. Graft failure IV. Immunologic mechanisms of corneal transplant rejection , 2008, International Ophthalmology.
[4] E. Tasciotti,et al. Proteomic Profiling of a Biomimetic Drug Delivery Platform. , 2014, Current drug targets.
[5] Anne L. van de Ven,et al. Cell source determines the immunological impact of biomimetic nanoparticles. , 2016, Biomaterials.
[6] J. Kovarik,et al. Minor influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine. , 1994, Transplantation proceedings.
[7] G. Kwon,et al. Polymeric micelles for drug delivery. , 2006, Current pharmaceutical design.
[8] Mauro Ferrari,et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.
[9] B. Sitharaman,et al. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents. , 2005, Journal of the American Chemical Society.
[10] Mauro Ferrari,et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[11] P. Vos,et al. Cell encapsulation: Promise and progress , 2003, Nature Medicine.
[12] K. Kataoka,et al. Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.
[13] Rishi Paliwal,et al. Nanocarriers in ocular drug delivery: an update review. , 2009, Current pharmaceutical design.
[14] M. Olson. Applications for ROCK kinase inhibition. , 2008, Current opinion in cell biology.
[15] Panagiotis D. Karampourniotis,et al. Nanostructured porous silicon films for terahertz optics , 2012, Nanotechnology.
[16] Mauro Ferrari,et al. Multistage vector (MSV) therapeutics. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[17] Hak Soo Choi,et al. Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation , 2010, Molecular imaging.
[18] Mauro Ferrari,et al. Enabling individualized therapy through nanotechnology. , 2010, Pharmacological research.
[19] Mauro Ferrari,et al. A robust nanofluidic membrane with tunable zero-order release for implantable dose specific drug delivery. , 2010, Lab on a chip.
[20] Mauro Ferrari,et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast , 2010, Nature nanotechnology.
[21] M. Kloc,et al. Rock1 Inhibitor Abrogates Chronic Rejection in Rat Cardiac Model System , 2012 .
[22] Li Tang,et al. Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[23] Vivian Charles McAlister,et al. Liposomal Formulations of Tacrolimus and Rapamycin Increase Graft Survival and Fiber Outgrowth of Dopaminergic Grafts , 2004, Cell transplantation.
[24] Vítězslav Bryja,et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord , 2004, Journal of neuroscience research.
[25] A. S. Moses,et al. Imaging and drug delivery using theranostic nanoparticles. , 2010, Advanced drug delivery reviews.
[26] W. Ritschel. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral. , 1996, Clinical transplantation.
[27] M. Ferrari,et al. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics. , 2013, Biomaterials.
[28] M. Kloc,et al. Chronic allograft rejection: A significant hurdle to transplant success , 2014, Burns & Trauma.
[29] Björn Lemmer,et al. Chronobiology, drug-delivery, and chronotherapeutics. , 2007, Advanced drug delivery reviews.
[30] S. Oliveira,et al. Nanobody-based cancer therapy of solid tumors. , 2015, Nanomedicine.
[31] Hermann Brenner,et al. Kidney Graft Survival in Europe and the United States: Strikingly Different Long-Term Outcomes , 2013, Transplantation.
[32] A. Gabizon,et al. Polyethylene Glycol-Coated (Pegylated) Liposomal Doxorubicin , 2012, Drugs.
[33] Zongxi Li,et al. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. , 2010, Small.
[34] L. Canham,et al. The role of nanostructured mesoporous silicon in discriminating in vitro calcification for electrospun composite tissue engineering scaffolds. , 2011, Nanoscale.
[35] M. Ferrari,et al. Nanopore Technology for Biomedical Applications , 1999 .
[36] Benjamin Thierry,et al. Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells , 2009, Advanced materials.
[37] C. Harms,et al. Imaging early endothelial inflammation following stroke by core shell silica superparamagnetic glyconanoparticles that target selectin. , 2014, Nano letters.
[38] R. Muthupillai,et al. Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. , 2008, Nano letters.
[39] S. Nie,et al. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.
[40] P. Couvreur,et al. Nanotechnology: Intelligent Design to Treat Complex Disease , 2006, Pharmaceutical Research.
[41] Lesley W Chow,et al. Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. , 2008, Transplantation.
[42] S. Al-Swailem,et al. Graft failure: II. Ocular surface complications , 2008, International Ophthalmology.
[43] M. Schnitzler. Diabetes Mellitus After Kidney Transplantation in the United States , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[44] F. Lim,et al. Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.
[45] Yi-Xiang J. Wang. Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. , 2011, Quantitative imaging in medicine and surgery.
[46] Shelton D Caruthers,et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. , 2003, Cancer research.
[47] Serge Muyldermans,et al. Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.
[48] S. Ludtke,et al. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. , 2005, Chemical communications.
[49] M. Ferrari,et al. The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. , 2014, Biomaterials.
[50] Mauro Ferrari,et al. nan'o·tech·nol'o·gy n. , 2006, Nature nanotechnology.
[51] Shuren Hu,et al. Porous silicon ring resonator for compact, high sensitivity biosensing applications. , 2015, Optics express.
[52] R. Weissleder,et al. Imaging macrophages with nanoparticles. , 2014, Nature materials.
[53] E. Hoffman,et al. Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging. , 2003, Academic radiology.
[54] Jongyoon Han,et al. Molecular sieving using nanofilters: past, present and future. , 2008, Lab on a chip.
[55] Y. Liu,et al. Ultrasensitive nanosensors based on upconversion nanoparticles for selective hypoxia imaging in vivo upon near-infrared excitation. , 2014, Journal of the American Chemical Society.
[56] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[57] Zhuang Liu,et al. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. , 2009, Nature nanotechnology.
[58] Mauro Ferrari,et al. Nanochannel Technology for Constant Delivery of Chemotherapeutics: Beyond Metronomic Administration , 2011, Pharmaceutical Research.
[59] Bo Nilsson,et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study , 2011 .
[60] T. Mihaljevic,et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.
[61] Mauro Ferrari,et al. Hierarchical modeling of diffusive transport through nanochannels by coupling molecular dynamics with finite element method , 2011, J. Comput. Phys..
[62] M Ferrari,et al. Microfabricated immunoisolating biocapsules. , 1998, Biotechnology and bioengineering.
[63] Marcel Warntjes,et al. Gd2O3 nanoparticles in hematopoietic cells for MRI contrast enhancement , 2011, International journal of nanomedicine.
[64] Mauro Ferrari,et al. Investigating Islet Immunoisolation Parameters Using Microfabricated Membranes , 1998 .
[65] Xin Wang,et al. In vivo MR imaging of magnetically labeled mesenchymal stem cells transplanted into rat liver through hepatic arterial injection. , 2008, Contrast media & molecular imaging.
[66] A Grattoni,et al. Confinement effects on monosaccharide transport in nanochannels. , 2010, The journal of physical chemistry. B.
[67] Mauro Ferrari,et al. Sustained Zero‐Order Release of Intact Ultra‐Stable Drug‐Loaded Liposomes from an Implantable Nanochannel Delivery System , 2014, Advanced healthcare materials.
[68] P. de Vos,et al. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets. , 2002, Trends in molecular medicine.
[69] K. Tabbara. Pharmacologic strategies in the prevention and treatment of corneal transplant rejection , 2008, International Ophthalmology.
[70] F. Ris,et al. Clinical Magnetic Resonance Imaging of Pancreatic Islet Grafts After Iron Nanoparticle Labeling , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[71] S. Majumdar,et al. Injectable Lipid Emulsions—Advancements, Opportunities and Challenges , 2010, AAPS PharmSciTech.
[72] Silvia Ferrati,et al. MP43-20 NANOTECHNOLOGY-BASED IMPLANT FOR LONG TERM TESTOSTERONE REPLACEMENT , 2014 .
[73] R. D. Stulting,et al. Design and Methods of the Collaborative Corneal Transplantation Studies , 1993 .
[74] Do Kyung Kim,et al. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. , 2006, Journal of the American Chemical Society.
[75] G. Korbutt,et al. Improved survival of microencapsulated islets during in vitro culture and enhanced metabolic function following transplantation , 2004, Diabetologia.
[76] W. Kao,et al. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems , 2010, Expert opinion on drug delivery.
[77] M. Ferrari,et al. Scaling and crossovers in molecular transport in nano-fluidic systems , 2013 .
[78] M. Ferrari,et al. Enhanced MRI relaxivity of Gd(3+) -based contrast agents geometrically confined within porous nanoconstructs. , 2012, Contrast media & molecular imaging.
[79] Mauro Ferrari,et al. Characterization of a nanogland for the autotransplantation of human pancreatic islets. , 2013, Lab on a chip.
[80] Mauro Ferrari,et al. Multi-stage delivery nano-particle systems for therapeutic applications. , 2011, Biochimica et biophysica acta.
[81] M. Ferrari,et al. Nanodevices in diagnostics. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[82] J. Lewsey,et al. Survival after liver transplantation in the United Kingdom and Ireland compared with the United States , 2007, Gut.
[83] M. Ferrari,et al. Degradation and biocompatibility of multistage nanovectors in physiological systems. , 2014, Journal of biomedical materials research. Part A.
[84] R. Robertson. Islet transplantation as a treatment for diabetes - a work in progress. , 2004, The New England journal of medicine.
[85] Jun Lin,et al. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery. , 2013, Small.
[86] B. Kasiske,et al. US Renal Data System 2013 Annual Data Report. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[87] Nuria Sanvicens,et al. Multifunctional nanoparticles--properties and prospects for their use in human medicine. , 2008, Trends in biotechnology.
[88] Paola Nicolussi,et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents , 2012, Proceedings of the National Academy of Sciences.
[89] Mauro Ferrari,et al. Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications , 2012, Chinese science bulletin = Kexue tongbao.
[90] Mauro Ferrari,et al. Gated and near-surface diffusion of charged fullerenes in nanochannels. , 2011, ACS nano.
[91] S. Dhar,et al. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis , 2013, Proceedings of the National Academy of Sciences.
[92] Efstathios Karathanasis,et al. Targeted nanotechnology for cancer imaging. , 2014, Advanced drug delivery reviews.
[93] J. Bulte,et al. Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[94] Mauro Ferrari,et al. Hierarchically Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor Accumulation , 2014, Advanced functional materials.
[95] K. Sun,et al. The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. , 2010, Biomaterials.
[96] Mauro Ferrari,et al. Silicon-micromachined direct-pore filters for ultrafiltration , 1997, Photonics West - Biomedical Optics.
[97] Thomas F. George,et al. Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[98] V. Chekhonin,et al. VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[99] Aifei Wang,et al. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. , 2011, Journal of the American Chemical Society.
[100] Xiaoyuan Chen,et al. Nanoparticles for cell labeling. , 2011, Nanoscale.
[101] Silvia Ferrati,et al. The nanochannel delivery system for constant testosterone replacement therapy. , 2015, The journal of sexual medicine.
[102] S. Stupp,et al. Self-Assembly and Mineralization of Peptide-Amphiphile Nanofibers , 2001, Science.
[103] A. Humar,et al. American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[104] G. Kwon,et al. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[105] S. Yalkowsky,et al. Solubilization of rapamycin. , 2001, International journal of pharmaceutics.
[106] M. Ferrari,et al. Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors. , 2013, Small.
[107] Raoul Kopelman,et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.
[108] A. Gabizon,et al. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. , 1997, Drugs.
[109] M. Rosen,et al. Finding Fluorescent Needles in the Cardiac Haystack: Tracking Human Mesenchymal Stem Cells Labeled with Quantum Dots for Quantitative In Vivo Three‐Dimensional Fluorescence Analysis , 2007, Stem cells.
[110] D. Rhee,et al. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. , 2006, Current opinion in ophthalmology.
[111] M. Ferrari,et al. A low-voltage electrokinetic nanochannel drug delivery system. , 2011, Lab on a chip.
[112] Tatsuya Kin,et al. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression1 , 2003, Transplantation.
[113] Patrick V. Almeida,et al. The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. , 2013, Biomaterials.
[114] M. Ferrari,et al. Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. , 2015, Current drug targets.
[115] Sung Jae Kim,et al. Amplified electrokinetic response by concentration polarization near nanofluidic channel. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[116] Mauro Ferrari,et al. Cellular association and assembly of a multistage delivery system. , 2010, Small.
[117] Anna Moore,et al. In vivo imaging of islet transplantation , 2006, Nature Medicine.
[118] Peng Yang,et al. Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. , 2014, Biomaterials.
[119] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[120] T. Webster,et al. Nanotechnology and nanomaterials: Promises for improved tissue regeneration , 2009 .
[121] Mauro Ferrari,et al. Leveraging electrokinetics for the active control of dendritic fullerene-1 release across a nanochannel membrane. , 2015, Nanoscale.
[122] David N Firmin,et al. Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. , 2006, Tissue engineering.
[123] Jinming Gao,et al. Theranostic nanomedicine for cancer. , 2008, Nanomedicine.
[124] R. Bisht,et al. Chronomodulated drug delivery system: A comprehensive review on the recent advances in a new sub-discipline of ‘chronopharmaceutics’ , 2011 .
[125] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[126] Xiaoping Hu,et al. Long‐circulating liposomal contrast agents for magnetic resonance imaging , 2006, Magnetic resonance in medicine.
[128] Robert Langer,et al. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.
[129] I. K. Yazdi,et al. Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials. , 2015, Nanomedicine.
[130] Mauro Ferrari,et al. Leveraging nanochannels for universal, zero-order drug delivery in vivo. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[131] Igor L. Medintz,et al. Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.
[132] Ralph Weissleder,et al. A fluorescent nanosensor for apoptotic cells. , 2006, Nano letters.
[133] Mauro Ferrari,et al. Nanotechnologies and regenerative medical approaches for space and terrestrial medicine. , 2012, Aviation, space, and environmental medicine.
[134] Vivian Charles McAlister,et al. Oral delivery of liposomal tacrolimus: increased efficacy and reduced toxicity. , 1999, Transplantation proceedings.
[135] Li-Jiuan Shen,et al. Nanomedicines in renal transplant rejection – focus on sirolimus , 2007, International journal of nanomedicine.
[136] MRI of Auto-Transplantation of Bone Marrow-Derived Stem-Progenitor Cells for Potential Repair of Injured Arteries , 2012, PloS one.
[137] A Grattoni,et al. Nanochannel systems for personalized therapy and laboratory diagnostics. , 2010, Current pharmaceutical biotechnology.
[138] M. Kloc,et al. Downregulation of RhoA and changes in T cell cytoskeleton correlate with the abrogation of allograft rejection. , 2010, Transplant immunology.
[139] Anna Moore,et al. Magnetic Nanoparticles for Cancer Diagnosis and Therapy , 2012, Pharmaceutical Research.